CD44 and arthritic joint disease: Studies also revealed that treatment with anti-CD44 mAbs reduced the severity of arthritis in a collagen-induced mouse model for human rheumatoid arthritis (RA) (203–205) and reduced the diabetic activity in NOD nice (206).